DAISY MANALEL: Open Payments
NPI 1962773762 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,050 in 202 payments from 25 companies in 2025. Trend: 2023 $439 · 2024 $1,853 · 2025 $3,050
Food & beverage: $3,050
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 18 | $479 |
| ABBVIE INC. | 52 | $391 |
| Corcept Therapeutics | 9 | $339 |
| Kowa Pharmaceuticals America, Inc. | 12 | $208 |
| Sumitomo Pharma America, Inc. | 16 | $191 |
| Amgen Inc. | 14 | $159 |
| PFIZER INC. | 9 | $151 |
| Lilly USA, LLC | 14 | $149 |
| GlaxoSmithKline, LLC. | 11 | $139 |
| Exact Sciences Corporation | 5 | $101 |
Products named: Auvelity, Korlym, ZORYVE, GEMTESA, QULIPTA, REXULTI, TRELEGY ELLIPTA, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
